Neurotech startup Beacon Biosignals scores $27M to bring AI to EEG analysis
Beacon Biosignals technology analyzes EEGs to find insights brain activity. The company will use its new Series A financing to build alliances with more biopharmaceutical companies looking for insights about how their experimental brain therapies are working.